Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-06

FDA Approved: ZELBORAF — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Zelboraf (vemurafenib) submitted by Genentech, Inc., approving a change associated with the supplement. The action i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zelboraf (vemurafenib)

Snippet

SUPPL AP for ZELBORAF (VEMURAFENIB)